NCT04970043 2021-07-21Camrelizumab Combined With Pemetrexed and Carboplatin for the Study of EGFR-mutated Lung Squamous NSCLC TreatmentCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase NA Unknown58 enrolled